Drawbacks of artificial intelligence and their potential solutions in the healthcare sector

B Khan, H Fatima, A Qureshi, S Kumar… - Biomedical Materials & …, 2023 - Springer
Artificial intelligence (AI) has the potential to make substantial progress toward the goal of
making healthcare more personalized, predictive, preventative, and interactive. We believe …

Animal models and therapeutic molecular targets of cancer: utility and limitations

M Cekanova, K Rathore - Drug design, development and therapy, 2014 - Taylor & Francis
Cancer is the term used to describe over 100 diseases that share several common
hallmarks. Despite prevention, early detection, and novel therapies, cancer is still the …

[HTML][HTML] Re-evaluating the role of FOXOs in cancer

M Hornsveld, TB Dansen, PW Derksen… - Seminars in cancer …, 2018 - Elsevier
FOXO transcription factors are negatively regulated by the PI3K-PKB/AKT signaling pathway
and have been mainly considered to be tumor suppressors due to their inhibitory effect on …

SOX9 drives WNT pathway activation in prostate cancer

F Ma, H Ye, HH He, SJ Gerrin, S Chen… - The Journal of …, 2016 - Am Soc Clin Investig
The transcription factor SOX9 is critical for prostate development, and dysregulation of SOX9
is implicated in prostate cancer (PCa). However, the SOX9-dependent genes and pathways …

Development and characterisation of acquired radioresistant breast cancer cell lines

M Gray, AK Turnbull, C Ward, J Meehan… - Radiation …, 2019 - Springer
Background Radiotherapy plays an important role in the multimodal treatment of breast
cancer. The response of a breast tumour to radiation depends not only on its innate …

Anti-estrogen treatment in endometrial cancer: a systematic review

WJ Van Weelden, LFAG Massuger, Enitec… - Frontiers in …, 2019 - frontiersin.org
Introduction: Hormonal therapy in endometrial cancer (EC) is used for patients who wish to
preserve fertility and for patients with advanced or recurrent disease in a palliative setting …

Genomic profiling of metastatic castration-resistant prostate cancer samples resistant to androgen receptor pathway inhibitors

N Menssouri, L Poiraudeau, C Helissey, L Bigot… - Clinical Cancer …, 2023 - AACR
Purpose: The androgen receptor axis inhibitors (ARPI; eg, enzalutamide, abiraterone
acetate) are administered in daily practice for men with metastatic castration-resistant …

A microfluidic cancer-on-chip platform predicts drug response using organotypic tumor slice culture

S Chakrabarty, WF Quiros-Solano, MMP Kuijten… - Cancer research, 2022 - AACR
Optimal treatment of cancer requires diagnostic methods to facilitate therapy choice and
prevent ineffective treatments. Direct assessment of therapy response in viable tumor …

[HTML][HTML] Artificial intelligence in clinical health care applications

M Van Hartskamp, S Consoli, W Verhaegh… - Interactive journal of …, 2019 - i-jmr.org
The idea of artificial intelligence (AI) has a long history. It turned out, however, that reaching
intelligence at human levels is more complicated than originally anticipated. Currently, we …

Estrogen receptor pathway activity score to predict clinical response or resistance to neoadjuvant endocrine therapy in primary breast cancer

MA Inda, EJ Blok, PJK Kuppen, A Charehbili… - Molecular cancer …, 2020 - AACR
Endocrine therapy is important for management of patients with estrogen receptor (ER)–
positive breast cancer; however, positive ER staining does not reliably predict therapy …